Assessment of potential predictive value o f peripheral blood inflammatory indexes in 26 cases with soft tissue sarcoma treated by pazopanib: a retrospective study
CANCER MANAGEMENT AND RESEARCH, vol.11, pp.3445-3453, 2019 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 11
- Publication Date: 2019
- Doi Number: 10.2147/cmar.s191199
- Journal Name: CANCER MANAGEMENT AND RESEARCH
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.3445-3453
- Keywords: soft tissue sarcoma, STS, pazopanib, angiogenesis, inflammation, neutrophil-to-lymphocyte ratio, NLR, derived neutrophil-to-lymphocyte ratio, DNLR, PROGNOSTIC-FACTORS, LYMPHOCYTE RATIO, CANCER, ANGIOGENESIS, BIOMARKERS, NEUTROPHIL, SURVIVAL, MONOCYTE
- Open Archive Collection: AVESIS Open Access Collection
- Çukurova University Affiliated: Yes
Abstract
Purpose: The aim of this study was to evaluate the prognostic and predictive value o f neutrophilto-lymphocyte ratio (NLR), derived neutrophil-to-lymphocyte ratio (DNLR), lymphocyte-tomonocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) in soft tissue sarcoma (STS) cases treated with pazopanib.